Actelion Closes Acquisition of Privately-held Ceptaris Therapeutics

By WebmasterSeptember 19, 2013November 1st, 2024No Comments

Actelion Closes Acquisition of Privately-held Ceptaris Therapeutics Adding Valchlor to Actelion’s Product Portfolio
Read more here

Previous PostRelmada Therapeutics Inc. Completes $8.0 Million Capital Raise in Series A Financing
Next PostTREVENTIS Corporation Closes $4.4 Million Financing with Wellcome Trust